Dynamic Humeral Centering in Impingement Syndrome

Assistance Publique - Hôpitaux de Paris70 enrolled

Overview

The purpose of this study is to determine wether dynamic humeral centering is effective in patients with impingement syndrome of the shoulder

Clinical trial with randomization for treatment and physiotherapist

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Degenerative Rotator Cuff Disease With Impingement Syndrome

Interventions

Dynamic humeral centeringPROCEDURE

Dynamic humeral centering performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.

Nonspecific mobilisationPROCEDURE

Nonspecific mobilisation performed for 6 weeks, in 15 supervised individual outpatient sessions, plus daily home exercises for 12 months.

Eligibility

Sex: ALLMin age: 31 Years

Medical Language ↔ Plain English

Inclusion Criteria: * age \> 30 years * pain duration \> 1 month * presence of at least 2 positive impingement test results from Neer, Yocum and Hawkins testing * total Constant score \< 80. Exclusion Criteria: concerning the shoulder * stiffness * anteroposterior instability * tendinous calcification * corticosteroid injection within the previous 30 days * previous surgery * humeral fracture * inflammatory joint disease * neoplastic disorders

Locations (1)

Department of Rheumatology, Lariboisière Hospital

Paris, France

Outcomes

Primary Outcomes

Constant total score as a mean and by category

Time frame: at 3 months

Secondary Outcomes

Constant total score

Time frame: at 12 months

Constant subscores for pain, activity, mobility and strength, and self-assessed disability on a 0- to 100-point visual analog scale, and analgesic and nonsteroidal anti-inflammatory drug (NSAID) use

Time frame: at 3 months

Constant subscores for pain, activity, mobility and strength, and self-assessed disability on a 0- to 100-point visual analog scale, and analgesic and nonsteroidal anti-inflammatory drug (NSAID) use

Time frame: at 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.